Impaired BMPRII activity is also associated with pulmonary overexpression of inflammatory mediators including interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor, which are involved in leukocyte recruitment and PAH pathogenesis (90–92). Here, BMPR2 is linked to pulmonary arterial hypertension.